---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-23-001737"
form_type: "8-K"
ticker: "AGPU"
cik: "0001446159"
company_name: "Axe Compute Inc."
filed_at: "2023-03-16T23:59:59+00:00"
generated_at: "2026-06-18T00:24:41.119491+00:00"
event_type: "dividend"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Predictive Oncology issues Series F Preferred Stock dividend to secure reverse split votes

## Summary
- Board declared dividend of 1/1000th of a share of Series F Preferred for each common share, payable March 27, 2023.
- Series F Preferred has 1,000 votes per share (1,000 votes per 1/1000th share) but only votes on reverse stock split.
- Shares are non-transferable except with common; all not present at reverse split meeting will be automatically redeemed.
- Redemption consideration is $0.10 per ten shares; shares also redeemable upon Board order or stockholder approval of reverse split.

## SEC filing metadata
- accession: 0001171843-23-001737
- form_type: 8-K
- ticker: AGPU
- cik: 0001446159
- company_name: Axe Compute Inc.
- filed_at: 2023-03-16T23:59:59+00:00
- event_type: dividend
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.03, 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1446159/000117184323001737/0001171843-23-001737-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1446159/000117184323001737/f8k_031623.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-23-001737
- JSON: https://secwatch.observer/filing/0001171843-23-001737.json
- Plain text: https://secwatch.observer/filing/0001171843-23-001737.txt

## Key facts
- Governance Changes
  Axe Compute Inc.: Board of Directors declared a dividend of Series F Preferred Stock and established its terms, including voting rights, transferability, dividend rights, liquidation preference, and redemption provisions (effective 2023-03-16).
  - Change: bylaw amendment
  - Effective: 2023-03-16
  source text: On March 16, 2023, the board of directors (the “Board” ) of Predictive Oncology Inc. (the “Company” ) declared a dividend of one one-thousandth of a share of Series F Preferred Stock, par value $0.01 per share ( “Series F Preferred Stock” ), for each outstanding share of the Company’s common stock, par value $0.01 per share ( “Common Stock” ) to stockholders of record at 5:00 p.m. Eastern Time on March 27, 2023 (the “Record Date” ).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1446159/000117184323001737/0001171843-23-001737-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.